The Global Nanomedicine Market was valued at USD 207.91 Billion in 2025 and is projected to expand at a 12.1% CAGR from 2025 ...
Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Nanotechnology in Drug Delivery - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for ...
Dublin,, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Introspective Market Research is excited to unveil its latest report, "Nanotechnology Drug Delivery" This in-depth analysis shows that the global ...
A team of University of Melbourne researchers from the Caruso Nanoengineering Group has created an innovative drug delivery system with outstanding potential to improve drug development. The team has ...
A team of researchers has created an innovative drug delivery system with outstanding potential to improve drug development. A team of University of Melbourne researchers from the Caruso ...
Scientists say a single FAP molecule enacts two roles, blocking a protein involved in scarring while helping turn hard-to-dissolve drugs into tiny particles that reach fibrotic tissue more effectively ...
A group of University of Ottawa researchers have already shown how scientists can harness gene therapies to deliver nano-sized treatments for cancer, cardiovascular and other diseases. Unfortunately, ...
Collaboration intended to develop large-scale, GMP-compliant ALD manufacturing equipment supporting Nanexa’s broad portfolio ...
Nano-drug delivery techniques have expanded the possibilities for delivering a broad spectrum of biomolecular and synthetic therapeutic agents into a body target region. The characterization of ...
Melanoma is among the most aggressive forms of skin cancer, characterised by rapid proliferation, early metastasis and resistance to conventional chemotherapeutics. Surgical excision remains the ...
Nanotechnology-based drug delivery systems have emerged as transformative platforms for the management of oral squamous cell carcinoma, offering precise targeting of malignant tissues while minimising ...
Forge Nano, Inc. announced a Joint Development Agreement (?JDA?) with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa?s PharmaShell® drug delivery platform and its ...